Chi-Ming Li
- Molecular Biology top 10%
- Renal and related cancers 4
- Glycosylation and Glycoproteins Research 3
- Single-cell and spatial transcriptomics 3
- Immunology top 10%
- T-cell and B-cell Immunology 6
- Immune Cell Function and Interaction 5
- Immunotherapy and Immune Responses 3
- Cell Biology top 10%
- Physiology top 10%
- Neurology top 10%
-
- CAR-T cell therapy research 5
-
- Multiple Myeloma Research and Treatments 3
- Co-authors
- Benjamin TyckoJan KitajewskiCarrie J. ShawberYasuhiro FunahashiEdward H. SchuchmanKonrad SandhoffJ. KochMichelle Wei
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Chi-Ming Li
43 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 98
- Molecular Biology 1.1k
- Immunology 241
- Cell Biology 171
- Physiology 258
- Neurology 77
Countries citing papers authored by Chi-Ming Li
This map shows the geographic impact of Chi-Ming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi-Ming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi-Ming Li more than expected).
Fields of papers citing papers by Chi-Ming Li
This network shows the impact of papers produced by Chi-Ming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi-Ming Li. The network helps show where Chi-Ming Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chi-Ming Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 11 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 34 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 4 | |
| 6 | 2022 | 8 | |
| 7 | 2021 | 14 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 7 | |
| 10 | 2021 | 52 | |
| 11 | 2020 | 37 | |
| 12 | 2020 | 39 | |
| 13 | 2018 | 69 | |
| 14 | 2017 | 8 | |
| 15 | 2015 | 24 | |
| 16 | 2005 | 219 | |
| 17 | 2004 | 15 | |
| 18 | 2002 | 196 | |
| 19 | 1998 | 92 | |
| 20 | 1996 | 204 |
About Chi-Ming Li
Chi-Ming Li is a scholar working on Immunology, Molecular Biology and Oncology, having authored 45 papers that have together received 1.6k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (6 papers), CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers), Renal and related cancers (4 papers), Glycosylation and Glycoproteins Research (3 papers), Single-cell and spatial transcriptomics (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Molecular Biology (1.1k citations), Immunology (241 citations) and Cell Biology (171 citations). Chi-Ming Li has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Benjamin Tycko, Jan Kitajewski, Carrie J. Shawber, Yasuhiro Funahashi, Edward H. Schuchman, Konrad Sandhoff, J. Koch, Michelle Wei, Harshwardhan M. Thaker and Ulf Klein. Their work appears in journals such as Genomics, Scientific Reports, Blood, Frontiers in Immunology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.